6th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 28-30 | London, UK
Ethical, Regulatory, and Commercial Aspects
The advancement of regenerative technologies demands careful alignment with societal values, legal frameworks, and business viability. Ethical, regulatory, and commercial aspects address questions of patient consent, long-term safety, equitable access, and sustainability of emerging therapies. The global expansion of clinical trials and biotechnological innovation calls for harmonized approval processes and transparent standards. Commercial strategies must balance profitability with public good, encouraging innovation while maintaining accountability. Ethical, regulatory, and commercial aspects also include intellectual property rights, pricing models, and education for both clinicians and patients. Navigating this complex terrain is essential for responsible translation of regenerative science into accessible and ethically sound healthcare solutions.
Kunal Mitra
Florida Tech, United States
Ivan Kelnar
Institute of Macromolecular Chemistry, Czech Academy of Sciences, Czech Republic
Lucie Bacakova
Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Patrizia Ferretti
UCL Great Ormond Street Institute of Child Health, United Kingdom
Gokarneshan Narayanan
SSM College of Engineering (Formerly), India
Sandeep Shrivastava
Datta Meghe Institute of Medical Sciences, India
Vasiliki E Kalodimou
European University-Cyprus Ltd, CyprusSubmit your abstract Today
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation